CAMG Solamere Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,820
Closed -$322K 93
2019
Q2
$322K Sell
3,820
-100
-3% -$7.87K 0.15% 75
2019
Q1
$313K Hold
3,920
0.16% 79
2018
Q4
$284K Sell
3,920
-296
-7% -$20.8K 0.16% 81
2018
Q3
$308K Sell
4,216
-1,421
-25% -$93.3K 0.16% 90
2018
Q2
$344K Sell
5,637
-158
-3% -$9.58K 0.17% 100
2018
Q1
$349K Hold
5,795
0.16% 108
2017
Q4
$330K Hold
5,795
0.15% 114
2017
Q3
$308K Buy
5,795
+1,214
+27% +$60.9K 0.15% 113
2017
Q2
$223K Buy
4,581
+21
+0.5% +$951 0.13% 116
2017
Q1
$202K Sell
4,560
-800
-15% -$34.6K 0.12% 117
2016
Q4
$206K Buy
+5,360
New +$213K 0.15% 118

Other funds holding ABT

CAMG Solamere Management's ABT Position: Q3 2019 in Review

CAMG Solamere Management sold out of Abbott (ABT) in Q3 2019, closing a stake of 3,820 shares — an estimated $322K sold.

CAMG Solamere Management first reported a position in ABT in Q4 2016 and held it in 11 quarters. The position peaked at $349K in Q1 2018. 2,029 funds tracked by Wall St. Rank hold ABT as of Q3 2019.

  • CAMG Solamere Management reported no remaining Abbott position as of Q3 2019 after selling out during the quarter.
  • CAMG Solamere Management sold 3,820 Abbott shares in Q3 2019, an estimated $322K.
  • CAMG Solamere Management first reported a position in Abbott in Q4 2016 and held it in 11 quarters.
  • CAMG Solamere Management's Abbott position peaked at $349K in Q1 2018.
  • 2,029 funds tracked by Wall St. Rank held Abbott as of Q3 2019.

Based on CAMG Solamere Management's 13F filing for Q3 2019, filed 14 Nov 2019.